Autism treatment: Dietary supplement OSR#1 pulled off shelves after FDA warning

July 28, 2010 in Special Needs News by Admin Dawn

Pharmacies are halting sales of OSR#1, a compound marketed as a dietary supplement to parents of children with autism, six weeks after the U.S. Food and Drug Administration called the product an unapproved new drug.

Several pharmacists told the Tribune they received an e-mail last week from Boyd Haley, president of the company that makes the product, informing them that OSR#1 would not be available after Thursday.

read more at Autism treatment: Dietary supplement OSR#1 pulled off shelves after FDA warning – chicagotribune.com.

Related Articles:

Want to get more out of our site? Join our community!